402 related articles for article (PubMed ID: 36947811)
1. Always stressed but never exhausted: how stem cells in myeloid neoplasms avoid extinction in inflammatory conditions.
Zhao HG; Deininger M
Blood; 2023 Jun; 141(23):2797-2812. PubMed ID: 36947811
[TBL] [Abstract][Full Text] [Related]
2. The regulation of normal and neoplastic hematopoiesis is dependent on microenvironmental cells.
Kaushansky K; Zhan H
Adv Biol Regul; 2018 Aug; 69():11-15. PubMed ID: 29970351
[TBL] [Abstract][Full Text] [Related]
3. Myeloproliferative neoplasm stem cells.
Mead AJ; Mullally A
Blood; 2017 Mar; 129(12):1607-1616. PubMed ID: 28159736
[TBL] [Abstract][Full Text] [Related]
4. JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β.
Yan Y; Dong L; Chen C; Bunting KD; Li Q; Stieglitz E; Loh ML; Qu CK
Blood Adv; 2022 Jan; 6(1):200-206. PubMed ID: 34555844
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms.
Sharma V; Wright KL; Epling-Burnette PK; Reuther GW
Front Immunol; 2020; 11():604142. PubMed ID: 33329600
[TBL] [Abstract][Full Text] [Related]
6. Protection of hematopoietic stem cells from stress-induced exhaustion and aging.
Singh S; Jakubison B; Keller JR
Curr Opin Hematol; 2020 Jul; 27(4):225-231. PubMed ID: 32398455
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms.
Fisher DAC; Fowles JS; Zhou A; Oh ST
Front Immunol; 2021; 12():683401. PubMed ID: 34140953
[TBL] [Abstract][Full Text] [Related]
8. Role of Inflammatory Factors during Disease Pathogenesis and Stem Cell Transplantation in Myeloproliferative Neoplasms.
Chatain N; Koschmieder S; Jost E
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32806517
[TBL] [Abstract][Full Text] [Related]
9. Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in mice.
Shide K; Kameda T; Kamiunten A; Ozono Y; Tahira Y; Yokomizo-Nakano T; Kubota S; Ono M; Ikeda K; Sekine M; Akizuki K; Nakamura K; Hidaka T; Kubuki Y; Iwakiri H; Hasuike S; Nagata K; Sashida G; Shimoda K
Blood; 2020 Jul; 136(1):106-118. PubMed ID: 32219445
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pathogenesis of Myeloproliferative Neoplasms.
Rolles B; Mullally A
Curr Hematol Malig Rep; 2022 Dec; 17(6):319-329. PubMed ID: 36336766
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis and clonal evolution of myeloproliferative neoplasms.
Cleary C; Kralovics R
Clin Chem Lab Med; 2013 Oct; 51(10):1889-96. PubMed ID: 23729579
[TBL] [Abstract][Full Text] [Related]
12. Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells.
Bao EL; Nandakumar SK; Liao X; Bick AG; Karjalainen J; Tabaka M; Gan OI; Havulinna AS; Kiiskinen TTJ; Lareau CA; de Lapuente Portilla AL; Li B; Emdin C; Codd V; Nelson CP; Walker CJ; Churchhouse C; de la Chapelle A; Klein DE; Nilsson B; Wilson PWF; Cho K; Pyarajan S; Gaziano JM; Samani NJ; ; ; Regev A; Palotie A; Neale BM; Dick JE; Natarajan P; O'Donnell CJ; Daly MJ; Milyavsky M; Kathiresan S; Sankaran VG
Nature; 2020 Oct; 586(7831):769-775. PubMed ID: 33057200
[TBL] [Abstract][Full Text] [Related]
13. Targeting Immune Signaling Pathways in Clonal Hematopoiesis.
Azrakhsh NA; Mensah-Glanowska P; Sand K; Kittang AO
Curr Med Chem; 2019; 26(28):5262-5277. PubMed ID: 30907306
[TBL] [Abstract][Full Text] [Related]
14. Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.
Yung Y; Lee E; Chu HT; Yip PK; Gill H
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440869
[TBL] [Abstract][Full Text] [Related]
15. Clonal hematopoiesis in hematological disorders: Three different scenarios.
Swierczek S; Prchal JT
Exp Hematol; 2020 Mar; 83():57-65. PubMed ID: 32007480
[TBL] [Abstract][Full Text] [Related]
16. The role of HMGA2 in the proliferation and expansion of a hematopoietic cell in myeloproliferative neoplasms.
Ikeda K; Ogawa K; Takeishi Y
Fukushima J Med Sci; 2012; 58(2):91-100. PubMed ID: 23237864
[TBL] [Abstract][Full Text] [Related]
17. IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.
Rai S; Zhang Y; Grockowiak E; Kimmerlin Q; Hansen N; Stoll CB; Usart M; Luque Paz D; Hao-Shen H; Zhu Y; Roux J; Bader MS; Dirnhofer S; Farady CJ; Schroeder T; Méndez-Ferrer S; Skoda RC
Blood Adv; 2024 Mar; 8(5):1234-1249. PubMed ID: 38207211
[TBL] [Abstract][Full Text] [Related]
18. The JAK2 mutation.
Merchant S
Int Rev Cell Mol Biol; 2021; 365():117-162. PubMed ID: 34756242
[TBL] [Abstract][Full Text] [Related]
19. Overview of Transgenic Mouse Models of Myeloproliferative Neoplasms (MPNs).
Dunbar A; Nazir A; Levine R
Curr Protoc Pharmacol; 2017 Jun; 77():14.40.1-14.40.19. PubMed ID: 28640953
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia cells secrete microRNA-4532-containing exosomes to mediate normal hematopoiesis in hematopoietic stem cells by activating the LDOC1-dependent STAT3 signaling pathway.
Zhao C; Du F; Zhao Y; Wang S; Qi L
Stem Cell Res Ther; 2019 Dec; 10(1):384. PubMed ID: 31842997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
